Diabetes
Conference Coverage
CKD considered a type 2 diabetes risk equivalent in CAD patients
Key clinical point: Type 2 diabetes and chronic kidney disease contribute synergistically to cardiac event risk in patients with established...
News
Out-of-pocket insulin cost has nearly doubled
Key clinical point: The use and cost of analog insulins rose significantly from 2000 to 2010.Major finding: Only 18.9% of patients filled (and...
News
Adding insulin to metformin may raise CVD risks
Key clinical point: Adding a sulfonylurea to metformin appears safer than adding insulin in terms of cardiovascular outcomes.Major finding: The...
News
Cardiometabolic risk increased with obesity and abnormal blood glucose
Key clinical point: Physical activity was shown to significantly reduce the risk of metabolic syndrome in women.Major finding: Among 866...
News
One in 10 heart attack patients has unrecognized diabetes
Key clinical point: Obtaining a HbA1c level in patients presenting with an acute MI who are not known to have diabetes will help identify those...
News
Type 2 diabetes remits in some bariatric surgery patients
Key clinical point: Bariatric surgery was linked to type 2 diabetes remission in some moderately obese patients.Major finding: Complete remission...
News
In diabetes, women far more likely to develop CHD than men
Key clinical point: Consider screening asymptomatic women for diabetes and offering risk factor management. Major finding: Women with diabetes...
Conference Coverage
Insulin perturbations seen in nondiabetic patients with NAFLD
Major finding: The mean fasting insulin level was 14.3 microIU/mL, and mean insulin levels on an OGTT exceeded the upper limit of normal from 60...
Conference Coverage
Liraglutide gains clout as weight loss agent for overweight, nondiabetic patients
Major finding: Patients in the liraglutide group lost 8.0% of their body weight, whereas the placebo group lost 2.6%.Data source: A randomized...
Conference Coverage
Testosterone is insulin sensitizing in diabetic men with hypogonadism
Major finding: Insulin sensitivity improved by 32% in the testosterone group but remained the same in the placebo group.Data source: A randomized...
Conference Coverage
Evolocumab lowers LDL-C with no effect on glucose metabolism
Major finding: Evolocumab was associated with a reduction in LDL-C levels (–47% to –52%), compared with standard of care (0%), without any...